SCHEMBL17626183

SCHEMBL17626183

Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccn3)cc2)n(C)c1=O

nearest known ligand 0.69

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PORCN Q9H237 3/20 0.69
▸ TRPA1 O75762 3/20 0.67
▸ RXFP1 Q9HBX9 6/20 0.66
▸ TP53 P04637 3/20 0.66
▸ CYP1A2 P05177 1/20 0.64
▸ THRB P10828 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ GAA P10253 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ TSHR P16473 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17626232 0.89 PORCN (0.69) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL17628710 0.89 RXFP1 (0.73) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL10114180 0.89 PORCN (0.76) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL17626355 0.89 PORCN (0.67) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL17636788 0.88 PORCN (0.69) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL17628659 0.87 PORCN (0.80) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL4533692 0.86 RXFP1 (0.78) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL17626301 0.86 PORCN (0.73) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL10114018 0.85 TRPA1 (0.74) PORCNTRPA1RXFP1TP53CYP1A2
SCHEMBL17628711 0.85 PORCN (0.76) PORCNTRPA1RXFP1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559495-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2026-02-24 — — US disclosed
US-20230366031-A1 KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-11-16 — — US disclosed
US-20230366031-A1 KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-11-16 — — US disclosed
US-20230174533-A1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-06-08 — — US disclosed
US-20230174533-A1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-06-08 — — US disclosed
US-20230174533-A1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-06-08 — — US disclosed
US-11649505-B2 Kit for identifying malignancy, and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-05-16 — — US disclosed
US-11649505-B2 Kit for identifying malignancy, and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-05-16 — — US disclosed
US-11555037-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-01-17 — — US disclosed
CN-109776537-B Purine diones as WNT pathway modulators 新加坡科技研究局 2021-12-14 — — CN disclosed
US-9926320-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-03-27 — — US disclosed
US-9926320-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-03-27 — — US disclosed
US-9926320-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-03-27 — — US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed
US-20160090386-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-03-31 — — US disclosed
US-20160090386-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-03-31 — — US disclosed
US-20160090386-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-03-31 — — US disclosed
EP-2999699-A1 PURINE DIONES AS WNT PATHWAY MODULATORS Agency For Science, Technology And Research (SG) 2016-03-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11649505-B2 Kit for identifying malignancy, and uses thereof KIT, WNT1, WNT3 PORCN 4185/4885TRPA1 4847/4885RXFP1 526/4885
US-20230366031-A1 KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF KIT, WNT1, WNT3 PORCN 4185/4885TRPA1 4847/4885RXFP1 526/4885
US-20160090386-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 PORCN 3761/4885TRPA1 1560/4885RXFP1 1132/4885
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 PORCN 3761/4885TRPA1 1560/4885RXFP1 1132/4885
US-11555037-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, WNT3 PORCN 3369/4885TRPA1 1933/4885RXFP1 1029/4885
US-20230174533-A1 PURINE DIONES AS WNT PATHWAY MODULATORS WNT1, WNT3A, WNT3 PORCN 3369/4885TRPA1 1933/4885RXFP1 1029/4885
US-12559495-B2 Purine diones as Wnt pathway modulators WNT1, CTNND1, WNT3A PORCN 3529/4885TRPA1 468/4885RXFP1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback